- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Eurofins Viacor BioPharma Services to Relocate to New Facility in Lenexa, KS | ||
| Fr | Accro Bioscience Grants Fosun Pharma Exclusive Rights for TYK2/JAK1 Inhibitor in Greater China | ||
| Fr | Symbiosis Appoints Wendy Cook as New Qualified Person | ||
| Fr | LSPedia Appoints Erin Parsons as Director of Compliance | ||
| Fr | Körber Introduces New PAS-X MES 3.4 | ||
| Fr | Foresee Pharmaceuticals Announces FDA Approval of CAMCEVI ETM | ||
| Fr | Santhera, Ikris Sign Agreement for Distribution of AGAMREE in India | ||
| Do | George Medicines & Piramal Pharma Develop Hypertension Drug | ||
| Do | FDA Accepts Gadoquatrane New Drug Application | ||
| Do | SGD Pharma to Acquire Alphial S.r.l. | ||
| Mi | FDA Approves Pfizer & BioNTech's Updated COVID-19 Vaccine for High-Risk Groups | ||
| Mi | MS Pharma Inaugurates Biologics Manufacturing Facility in Saudi Arabia | ||
| Mi | Novartis Licenses BioArctic's BrainTransporter Technology | ||
| Mi | Asimov, Ottimo Pharma Enter Cell Line Development Partnership | ||
| Mi | Cold Chain Technologies Bolsters Asia Pacific Presence | ||
| Mi | Asymchem Expands Flow Chemistry Capabilities in the UK | ||
| 26.08. | Bio-Thera's Biosimilar Referencing Stelara Approved in the EU | ||
| 26.08. | Bio-Rad Laboratories Introduces New Range of StarBright Dyes | ||
| 26.08. | Gilead Granted Marketing Authorization for Twice-Yearly HIV PrEP Shot in Europe | ||
| 26.08. | Acadia Names Konstantina Katcheves as Senior VP, Chief Business & Strategy Officer | ||
| 26.08. | AbbVie to Acquire Gilgamesh Pharmaceutical's Psychedelic Drug for $1.2B | ||
| 25.08. | Genentech Breaks Ground on Manufacturing Site in Holly Springs, NC | ||
| 25.08. | Adva and Autolomous Launch Digital Pioneer Program for Cell Therapy | ||
| 25.08. | Cambrex Expands Peptide Manufacturing Capabilities in Massachusetts | ||
| 25.08. | Incyte Taps Soni Basi as EVP and Chief Human Resources Officer |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .